Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study

Author: Polyzos N.P.   De Vos M.   Corona R.   Vloeberghs V.   Ortega-Hrepich C.   Stoop D.   Tournaye H.  

Publisher: Oxford University Press

ISSN: 1460-2350

Source: Human Reproduction, Vol.28, Iss.5, 2013-05, pp. : 1254-1260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract